Security · CUSIP 55083R104
Lyell Immunopharma, Inc.
COM · institutional ownership from 13F filings
13F holders
6
Shares held
2.4M
Value held
$21.6M
New / sold out
1 / 107
Added / reduced
0 / 5
net -149.9M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2025
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| MWG Management Ltd. | 1,008,116 | $8.9M | 17.17% |
| Orland Properties Ltd | 754,698 | $6.7M | 2.83% |
| Decheng Capital LLC | 595,466 | $5.3M | 1.33% |
| JOHNSON & JOHNSON | 41,165 | $368.0K | 0.11% |
| TAKEDA PHARMACEUTICAL CO LTD | 41,165 | $363.9K | 1.86% |
| IFP Advisors, Inc | 63 | $28 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| IFP Advisors, Inc | New | +63 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| MWG Management Ltd. | Reduced | -19,154,216 | -95.0% |
| Foresite Capital Management IV, LLC | Sold out | -16,007,999 | -100.0% |
| Orland Properties Ltd | Reduced | -14,339,271 | -95.0% |
| BlackRock, Inc. | Sold out | -12,721,571 | -100.0% |
| Decheng Capital LLC | Reduced | -11,313,875 | -95.0% |
| VANGUARD GROUP INC | Sold out | -9,737,729 | -100.0% |
| Foresite Capital Management V, LLC | Sold out | -8,133,047 | -100.0% |
| venBio Partners LLC | Sold out | -7,102,190 | -100.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -6,478,836 | -100.0% |
| Alphabet Inc. | Sold out | -5,865,125 | -100.0% |
102 more rows. Subscribe for $29/month to see every row, download the data and use the API.